dc.creatorGutierrez, Lucas Joel
dc.creatorBarrera Guisasola, Exequiel Ernesto
dc.creatorPeruchena, Nelida Maria
dc.creatorEnriz, Ricardo Daniel
dc.date.accessioned2019-08-13T13:42:54Z
dc.date.accessioned2022-10-15T12:22:14Z
dc.date.available2019-08-13T13:42:54Z
dc.date.available2022-10-15T12:22:14Z
dc.date.created2019-08-13T13:42:54Z
dc.date.issued2016-02
dc.identifierGutierrez, Lucas Joel; Barrera Guisasola, Exequiel Ernesto; Peruchena, Nelida Maria; Enriz, Ricardo Daniel; A QM/MM study of the molecular recognition site of bapineuzumab toward the amyloid-β peptide isoforms; Taylor & Francis Ltd; Molecular Simulation; 42; 3; 2-2016; 196-207
dc.identifier0892-7022
dc.identifierhttp://hdl.handle.net/11336/81540
dc.identifier1029-0435
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4385465
dc.description.abstractThe molecular mechanism of recognition of amyloid-beta (Aβ) peptide isoforms by bapineuzumab was studied using a quantum mechanics and molecular mechanics (QM/MM) method. In this work, geometric optimisations were performed using the ONIOM2 scheme (at B3LYP/6-31G(d) amber)EE level) on the paratope of bapineuzumab together with the different forms of Aβ peptide (AβWT and AβN3(pE)). A comprehensive study of the interactions was also performed through Quantum Theory of Atoms in Molecules (QTAIM). This allowed us to obtain a deep understanding of how this antibody interacts with the amino acids of the Aβ peptides. The description on the interactions between bapineuzumab and the different forms of Aβ peptides allow us to understand why the peptides that lack the two first residues (Asp1 and Ala2) and begin with a pyroglutamate residue present low affinity for bapineuzumab. This basic structural information is useful for a deeper understanding about the scope and limitations of bapineuzumab as a therapeutic agent for the AD.
dc.languageeng
dc.publisherTaylor & Francis Ltd
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1080/08927022.2015.1032276
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/abs/10.1080/08927022.2015.1032276
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectALZHEIMERS DISEASE
dc.subjectAMYLOID-BETA PEPTIDE
dc.subjectONIOM CALCULATIONS
dc.subjectQTAIM ANALYSIS
dc.titleA QM/MM study of the molecular recognition site of bapineuzumab toward the amyloid-β peptide isoforms
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución